Similar companies
Catalyst Pharmaceuticals X Follower Count
Catalyst Pharmaceuticals has 869 followers on X (formerly Twitter), roughly flat (+0.0%) over the past three months.
With 869 followers, Catalyst Pharmaceuticals has a smaller X following than industry peers like Amgen (118,880) and Gilead Sciences (72,417).
How Catalyst Pharmaceuticals’s X Growth Feeds the CPRX AI Score
X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Catalyst Pharmaceuticals’s X following into the CPRX AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.
For Catalyst Pharmaceuticals’s reach on other platforms, see Catalyst Pharmaceuticals Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.
For real-time conversation volume, see CPRX X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.
Month over Month
| Jun 2026 | 868 | |
| May 2026 | 865 | |
| Apr 2026 | 864 | |
| Mar 2026 | 864 | |
| Feb 2026 | 869 | |
| Jan 2026 | 870 |
Catalyst Pharmaceuticals X (Twitter) Followers: Frequently Asked Questions
Catalyst Pharmaceuticals has 869 followers (869) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.
Catalyst Pharmaceuticals's X following has been roughly flat (+0.0%) over the past three months. View the trend chart above for the full history.
X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Catalyst Pharmaceuticals's following can reflect shifting public interest. That is why AltIndex combines Catalyst Pharmaceuticals's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Catalyst Pharmaceuticals underperforms its industry peers when it comes to X Followers, ranking dead last.
With fewer than 1,000 followers, Catalyst Pharmaceuticals' X account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.
Sign up and get more insights on Catalyst Pharmaceuticals.
See Catalyst Pharmaceuticals’s complete x followers history
Sign up to unlock 1-year and all-time charts for CPRX — plus 25+ alternative data signals, AI Scores, and real-time alerts.
Sign up
